Cytokinetics CYTK
NASDAQ CYTK
$65.60 -0.02 (-0.03%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cytokinetics (CYTK) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Cytokinetics (CYTK) recorded Return on Capital Employed [ROCE] of -49.94% in Q2 2026, down 0.83 percentage points from -49.11% a year earlier but up 5.74 percentage points from the prior quarter.

Analysis

Cytokinetics (CYTK) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2025, Cytokinetics reported Return on Capital Employed [ROCE] of -50.57%, up 6.88 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has a five-year change of -25.89 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -57.46% in FY2024 (+3.29 pp), -60.74% in FY2023 (-22.31 pp), -38.44% in FY2022 (-8.18 pp) and -30.26% in FY2021 (-5.58 pp).
  • Quarterly Return on Capital Employed [ROCE] has ranged from -72.99% in Q4 2023 to -24.04% in Q2 2022 over the past five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has declined for five consecutive quarters, with an average year-over-year change of +7.26 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 34.35 percentage points in Q3 2024, against a drop of 46.81 percentage points in Q3 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at -55.68% (Q1 2026), -49.85% (Q4 2025) and -48.19% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Cytokinetics 9.12 Bn 5.29 Bn 25.89 Mn -49.94%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -49.94%
Mar 31, 2026 -55.68%
Dec 31, 2025 -49.85%
Sep 30, 2025 -48.19%
Jun 30, 2025 -49.11%
Mar 31, 2025 -48.22%
Dec 31, 2024 -43.27%
Sep 30, 2024 -38.29%
Jun 30, 2024 -47.60%
Mar 31, 2024 -68.46%
Dec 31, 2023 -72.99%
Sep 30, 2023 -72.64%
Jun 30, 2023 -62.66%
Mar 31, 2023 -42.28%
Dec 31, 2022 -33.74%
Sep 30, 2022 -25.83%
Jun 30, 2022 -24.04%
Mar 31, 2022 -28.59%
Dec 31, 2021 -24.43%
Sep 30, 2021 -32.68%
API Access

Cytokinetics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CYTK&period=max&api_key=YOUR_API_KEY